Recombinanr hhv8 dna
OwnerHenri-Jacques Delecluse, Manuela Kost +1inventors
InventorsHenri-Jacques Delecluse, Manuela Kost, Wolfgang Hammerschmidt
Life of this patent
Estimating the term…
Abstract
The present invention relates to recombinant HHV8 DNA as well as to methods for the preparation thereof.
Claims27
A recombinant HHV8 DNA wherein said DNA contains at least the information for the replication of HHV8 DNA in prokaryotes or yeasts as well as one or more maker gene(s) selectable in prokaryotes or yeasts and wherein at least one essential gene of HHV8 has been inactivated.
A HHV8 DNA according to one or more of the preceding claims wherein said essential gene has been inactivated by integration, deletion, addition or exchange of one or more nucleotides.
A HHV8 DNA according to one or more of the preceding claims wherein said essential gene is a gene encoding regulation of gene expression or encoding viral transcription factors.
A HHV8 DNA according to one or more of the preceding claims wherein the inactivation in the essential gene occurs in a gene encoding a protein for HHV8 DNA replication.
A HHV8 DNA according to one or more of the preceding claims wherein at least the information for replication in prokaryotes is derived from the E. coli F factor plasmid.
A HHV8 DNA according to one or more of the preceding claims wherein said DNA has a size of at least 100, 150, 170, 200, or up to 230 kbp or more.
A prokaryotic or a yeast cell containing the HHV8 DNA according to one or more of the preceding claims.
An animal or human eukaryotic cell containing a recombinant HHV8 DNA according to one or more of the preceding claims.
A eukaryotic cell according to one or more of the preceding claims wherein said cell further contains HHV8 DNA in which essential genes can not be inactivated.
A eukaryotic cell according to one or more of the preceding claims wherein the HHV8 DNA with essential genes which can not be inactivated is present in a latent form.
HHV8 virus particles containing HHV8 DNA according to one or more of the preceding claims.
A method for the preparation of a recombinant HHV8 DNA wherein said method comprises the introduction of DNA into the HHV8 genome which enables replication of the HHV8 DNA in prokaryotes or yeasts, and of one or more marker gene(s) selectable in prokaryotes or yeasts, as well as the inactivation of at least one gene essential for HHV8.
A method according to one or more of the preceding claims wherein said flanking homologous HHV8 sequences have a size of ≧300 bp, preferably ≧1 kbp or more.
A method according to one or more of the preceding claims wherein said DNA sequences introduced are derived from the E. coli F plasmid.
A method according to one or more of the preceding claims wherein said homologous flanking sequences are derived from a gene essential for HHV8.
A method according to one or more of the preceding claims wherein the homologous flanking sequences are derived from a gene responsible for lytic viral DNA replication of HHV8.
A method according to one or more of the preceding claims wherein said recombinant HHV8 DNA containing at least one essential gene of HHV8 which has been inactivated, a marker gene selectable in prokaryotic cells or in yeast cells as well as the information for the replication of HHV8 DNA in prokaryotes or yeast cells is introduced into an animal or human eukaryotic cell which contains HHV8 DNA without inactivation of the essential gene.
A method according to one or more of the preceding claims wherein in said eukaryotic cells containing the recombinant HHV8 DNA and the HHV8 DNA without inactivation of the essential gene the HHV8 lytic cycle is induced in order to induce the production of recombinant HHV8 virus genome.
The use of a recombinant DNA or RNA according to one or more of the preceding claims for further mutagenesis of HHV8 genes and for functional studies of HHV8.
Dependencies are inferred from the claim text.